Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIO) EBIT Margin (2022 - 2025)

Historic EBIT Margin for Cardio Diagnostics Holdings (CDIO) over the last 4 years, with Q3 2025 value amounting to 59950.86%.

  • Cardio Diagnostics Holdings' EBIT Margin fell 385379900.0% to 59950.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 41422.24%, marking a year-over-year decrease of 179088100.0%. This contributed to the annual value of 23977.86% for FY2024, which is 184625600.0% up from last year.
  • Cardio Diagnostics Holdings' EBIT Margin amounted to 59950.86% in Q3 2025, which was down 385379900.0% from 22457.51% recorded in Q2 2025.
  • Cardio Diagnostics Holdings' EBIT Margin's 5-year high stood at 14398.71% during Q3 2023, with a 5-year trough of 250321.79% in Q4 2022.
  • Its 4-year average for EBIT Margin is 72278.39%, with a median of 29039.51% in 2023.
  • As far as peak fluctuations go, Cardio Diagnostics Holdings' EBIT Margin skyrocketed by 2000000000bps in 2023, and later crashed by -1473585600bps in 2025.
  • Over the past 4 years, Cardio Diagnostics Holdings' EBIT Margin (Quarter) stood at 250321.79% in 2022, then skyrocketed by 88bps to 29039.51% in 2023, then decreased by -16bps to 33608.2% in 2024, then tumbled by -78bps to 59950.86% in 2025.
  • Its last three reported values are 59950.86% in Q3 2025, 22457.51% for Q2 2025, and 173463.83% during Q1 2025.